As part of the agreement, SSB will globally market and distribute complete Umetrics portfolio for the pharmaceutical and biopharmaceutical industries as well as integrate Umetrics software programs as private label products in its bioprocess portfolio and market them as stand-alone solutions under both brands under a dual branding arrangement.
SSB marketing senior vice president Stefan Schlack said, "These software solutions will help our customers to better understand their cell culture processes and to identify potential for optimization and robust process control – an ideal addition to our bioprocess portfolio."
Umetrics general manager Lars Lindstorm said with SSB, Umetrics can gain access to more customers.
"SSB’s integrated solutions for the complete biopharmaceutical process clearly create added value for our customers," Lindstorm added.
Umetrics’ chemometrics software systems include Multivariate data analysis (MVA) as well as DoE software (Design of Experiments).